New drug shows strong results against stubborn mutation

June 5, 2019 | Michael Easterling

A new drug being investigated by Marwan Fakih, M.D., professor in the Department of Medical Oncology & Therapeutics Research and medical director of the Judy & Bernard Briskin Center for Clinical Research, is "potentially practice-changing," Fakih said.

Continue Reading

Leukemia patient finds donor halfway around the world

May 9, 2019 | Letisia Marquez

Acute myeloid leukemia patient Leif Voeltz's perfect match for a bone marrow transplant was located in Germany. Now Marcel Waldmann is traveling to the U.S. for the first time to meet the man whose life he saved.

Def Leppard guitarist defies cancer diagnosis

March 29, 2019 | Samantha Bonar

Def Leppard guitarist Vivian Campbell was diagnosed with Hodgkin's lymphoma in 2013. After chemotherapy and a stem cell transplant failed, immunotherapy has kept his cancer at bay for the last four years.

City of hope's bone marrow transplant program reaches two historic milestones

February 26, 2019 | City of Hope

City of Hope’s bone marrow transplant has played a crucial role in the advancement of the procedure that it began doing more than four decades ago.

City of Hope doctor co-edits annual report highlighting cancer breakthroughs

January 31, 2019 | Michael Easterling

Sumanta K. Pal, M.D., was selected to serve as one of three editors of this year’s Clinical Cancer Advances, an annual report on the progress against cancer distributed by the American Society of Clinical Oncology.

Clinical research nurses: ‘Shepherds’ of the CAR T program

January 9, 2019 | Abe Rosenberg

What's it like to work at the center of a true medical and scientific revolution? It's emotional, often overwhelming. But it’s also a place to witness miracles. Such is the life of the clinical research nurses who staff City of Hope's CAR T cell program.

City of Hope investigators present breakthrough research at 60th American Society of Hematology meeting

December 5, 2018 | Letisia Marquez

Physicians and researchers at the 2018 American Society of Hematology conference presented clinical trials for new leukemia and lymphoma treatments, laying the groundwork for innovative therapeutic approaches aimed at improving treatment options and quality of life for patients.